FDA Investigator Henry K Lau
Henry K Lau has conducted inspections on 14 sites in 1 countries as of 20 May 2016. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
14
Last Inspection Date:
20 May 2016
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Henry K Lau:
Abdur Razzaque,
Alicia K Mckinsey,
Amir Alavi,
Andrea A Branche,
Andrea George, PhD,
Andrew B Slarve,
Andrew E Kay,
Andrew Le,
Andrew W Harmon,
Angel K Sandhu,
Angela D Wise,
Anh M Lac,
Anita Narula, PhD,
Anna J Vickrey,
Anney Lin,
Annie H Lam,
Ashar P Parikh,
Barbara J Arrais,
Barbara J Wilcox, PhD,
Bo Chi, PhD,
Brentley S Collins,
Calvin B Koerner,
Candace Y Gomez Broughton,
Carl Lee,
Carol A Elems,
Carole L Jones,
Carolyn A Renshaw,
CDR Ileana Barreto Pettit,
CDR Rochelle B Young, RPh, MSA,
Christian D Lynch (CDL),
Christine M Parmentier,
Christopher R Czajka,
Cynthia Jim, CSO,
Cynthia L Ford,
Daniel J Roberts,
David G Eng,
Doan T Nguyen, PharmD,
Dr. Guang Gao, PhD,
Dr. Mark J Seaton, PhD,
Dr. Ralph M Bernstein, PhD,
Dr. Zhou Chen (nmi), MD PhD,
Dustin P Tran,
Dustin R Abaonza,
Eileen A Liu,
Elsa Y Yu,
Emily Shacter,
Emmanuel Adu Gyamfi, PhD,
Eric L Dong, BS,
Erica R Pomeroy,
Farhana Khan,
Gene D Arcy,
Gerald Feldman,
Gerald M Feldman, PhD,
Gillenwater,
Gina M Hall,
Hung H Do, MS,
Huy T Pham,
Jacqueline Mdiaz Albertini,
James C Yee,
James R Evans,
Jane M Kreis,
Janice Wai,
Jannifer L Degroot,
Jeanmaire Hryshko,
Jeanne A Young,
Jeanne Fringer, PhD,
Jeffrey M Watson,
Jeffrey P Raimondi,
Jennifer L Johnson,
Jenny K Yee,
Jessica B Darneille,
Joan T Briones,
Joey V Quitania,
John A Gonzalez,
Jolanna A Norton,
Joseph Kutze, PhD,
Joseph P Iser, MD,
Joseph Tibay,
Joshua S Hunt,
Joslyn K Brunelle, PhD,
Juliane Kjung Lau,
Karen D Phung,
Kathryn E King,
Keith O Webber, PhD,
Keith Webber, PhD,
Kevin P Foley,
Kouros Kangarli,
Kristin M Abaonza,
Kula N Jha,
Lakisha M Williams,
Lance Mde Souza, MBA,
Laura Fontan, MS,
Laurie Graham,
Laurie P Norwood,
LCDR Jennifer H Rhyu,
Lealand Lee,
Linan Ha, PhD,
Linda S Shook,
Linh Tu,
Lisa Shin,
Lucila B Nwatu,
Lydia S Chan,
Mabel M Lee,
Maida Henesian (NMI),
Marie K Kinkade,
Marissa J Chan,
Mariza M Jafary,
Marsha W Major,
Marshalette O Edwards,
Mei Chiung Huang (Jo),
Michael Shanks, MS,
Michael T Cyrus,
Michelle Rfrazier Jessen, PhD,
Mihaly S Ligmond,
Milos Dokmanovic, PhD,
Min Shanmabel Liu,
Natalia Pripuzova, PhD,
Nayan J Patel,
Nicholas L Hunt,
Nicholas Obiri, PhD,
Omotunde O Osunsanmi,
Patricia F Hughes, PhD,
Paula A Trost,
Peter E Baker,
Peter Kessler, PhD,
Prabhu P Raju,
Qing Joanna Zhou, PhD,
Rachel C Harrington,
Randy L Elsberry,
Raymond T Oji,
Rebecca Rodriguez,
Rebecca T Davis,
Reyes Candau Chacon, PhD,
Riley C Myers, PhD,
Robert D Tollefsen,
Rose Ashley,
Ruth Moore, PhD,
Sabino S Camacho,
Sandra S Saniga,
Scott N Lim,
Serge L Beaucage,
Sharon K Thoma, PharmD,
Sheilyn H Huang,
Shelley H Beausoleil,
Sherri J Jackson,
Sidney B Priesmeyer,
Stephanie A Slater, MS,
Steven C Himebaugh,
Stuart W Russell,
Thea C Grome,
Thomas J Arista,
Thomas R Withers,
Thuy T Nguyen, LCDR,
Timothy C Grome,
Truong Xuan Nguyen (Andy),
Uduak M Inokon,
Uttaniti Limchumroon (Tom),
Victoria Taylor,
Walden H Lee,
William J Weis,
William V Millar,
Yi Wang, PhD,
Ying Xin Fan, PhD,
Yiyue Zhang (nmi), PhD
Henry K Lau's Documents
| Publish Date | Document Type | Title |
|---|---|---|
| September, 2013 | FDA 483 | Genentech, Inc. - Form 483, 2013-09-06 |
| March, 2013 | FDA 483 | FVS Holdings, Inc. dba. Green Valley Drugs - Form 483, 2013-03-15 |
| June, 2016 | FDA 483 | Jajco, Inc. DBA Anchor Drugs Pharmacy - Form 483, 2016-06-03 |
| March, 2014 | FDA 483 | Wedgewood Connect, LLC - Form 483, 2014-03-06 |
| March, 2014 | FDA 483 Response | Wedgewood Connect, LLC - Form 483R, 2014-03-26 |
| February, 2008 | EIR | Grifols Diagnostic Solutions Inc. - EIR, 2008-02-01 |
| September, 2011 | FDA 483 | Genentech, Inc. - Form 483, 2011-09-27 |
| May, 2013 | FDA 483 | Allure Labs, Inc - Form 483, 2013-05-24 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more